Patent details

EP3258931 Title: USE OF CABAZITAXEL IN THE TREATMENT OF PROSTATE CANCER

Basic Information

Publication number:
EP3258931
PCT Application Number:
NL2016050111
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167145754
PCT Publication Number:
WO2016133387
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF CABAZITAXEL IN THE TREATMENT OF PROSTATE CANCER
French Title of Invention:
UTILISATION DE CABAZITAXEL POUR LE TRAITEMENT DU CANCER DE LA PROSTATE
German Title of Invention:
VERWENDUNG VON CABAZITAXEL ZUR BEHANDLUNG VON PROSTATAKREBS
SPC Number:

Dates

Filing date:
17/02/2016
Grant date:
12/08/2020
EP Publication Date:
27/12/2017
PCT Publication Date:
25/08/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/08/2020
EP B1 Publication Date:
12/08/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/02/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/08/2020
 
 

Name:
Erasmus University Medical Center Rotterdam
Address:
Dr. Molewaterplein 50, 3015 GE Rotterdam, Netherlands (NL)

Inventor

1

Name:
SIEUWERTS, Anita Maria
Address:
Netherlands (NL)

2

Name:
ONSTENK, Wendy
Address:
Netherlands (NL)

3

Name:
SLEIJFER, Stefan
Address:
Netherlands (NL)

Priority

Priority Number:
15155470
Priority Date:
17/02/2015
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/337; A61K 31/573; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202033
Publication date:
12/08/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/08/2021
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages